Latest news for M3 (OTC:MTHRF) Stock

M3 Inc is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.

News

Intraday Update

Markets

Movers

Trading Ideas

ADES

ANSS

ARMK

ASMIY

ATEYY

AVGOP

BLDR

BONZ

BPYPP

BTDPF

CCRC

CELG

CELP

CHAG

CLHI

CLSI

CNSWF

CRVH

CRWS

CSVI

ECMH

ENGIY

EXLA

GLAD

GRBK

HCHMY

HELE

Hannover Ruckversicherungs Registered shares 

HVRRY

IBKCO

JACK

JRONF

LCSHF

LMRK

MANT

MTHRF

NCBDF

NXPI

OMRNY

ORKLF

ORKLY

PCTI

PFPT

PNNB

RLBY

ROST

SBAZ

SBGL

SECCF

SEOJF

SEOVF

SFNXF

SKAS

SKSBF

SMTI

SPNS

SSREF

STIE

TERP

TMHC

TRCB

TREX

TSCHY

TTEK

TYOYY

USCR

UTRX

VOPKF

Stocks That Hit 52-Week Highs On Tuesday

ACGL

ACLLF

ATAX

AVACF

BOREF

BVFL

BYCBF

CBNC

CHCT

CPKF

DLTR

DNPLY

DOVA

EVLLF

FFDF

GLAXF

GLSDP

HGBL

IRET

JBSS

LEAI

MSEX

MINEWORX TECH LTD ORD by Mineworx Technologies Ltd.

MWXRF

PLOW

PODD

PURY

RHHBY

RITT

RTOKY

SGEN

SOHON

SOHOO

SQNXF

STRB

TLTZF

URYL

VENV

WMCB

YORW

ARTR

NLLSY

ELALF

CRZHF

MISM

CBBB

Stocks That Hit 52-Week Highs On Monday

M3 Inc

Barclays analyst Simon Coles downgrades STMicroelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) from Equal-Weight to Underweight.

Downgrades

Analyst Ratings

Barclays Downgrades STMicroelectronics to Underweight

JP Morgan analyst Mark Murphy downgrades Paycor HCM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) from Neutral to Underweight and raises the price target from $21 to $22.5.

Price Target

PYCR

JP Morgan Downgrades Paycor HCM to Underweight, Raises Price Target to $22.5

JP Morgan analyst James Kirby initiates coverage on Sun Country Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCY#NASDAQ">SNCY</a>) with a Overweight rating and announces Price Target of $23.

Initiation

SNCY

JP Morgan Initiates Coverage On Sun Country Airlines with Overweight Rating, Announces Price Target of $23

JP Morgan analyst DS Kim downgrades New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) from Overweight to Neutral and lowers the price target from $85 to $50.

New Oriental Education & Technology Group

JP Morgan Downgrades New Oriental Education to Neutral, Lowers Price Target to $50

Tesla Inc. CEO Elon Musk cast doubt Wednesday on the ambitious $500 billion Project Stargate, hours after its announcement, claiming lead investor SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) has &#8220;well under $10B secured.&#8221;
What Happened: The project, unveiled Tuesday at a White House briefing in the presence of President Donald Trump, represents a joint venture between OpenAI, SoftBank, and Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) to establish massive <a href="https://www.benzinga.com/25/01/43111153/nvidia-and-ai-stock-rises-as-trump-announces-500-billion-stargate-ai-infrastructure-venture">artificial intelligence infrastructure across the United States</a>. 
&#8220;They don't actually have the money,&#8221; Musk said.
&#8220;SoftBank has well under $10B secured. I have that on good authority.&#8221;
During the briefing, Oracle co-founder Larry Ellison highlighted the project&#8217;s healthcare applications, including an AI-driven system capable of delivering personalized cancer vaccines within 48 hours. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">SoftBank has well under $10B secured. I have that on good authority.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1881944244480565497?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/general/biotech/25/01/43119814/google-parent-owned-startup-to-launch-ai-designed-drug-trials-by-year-end-partnering-with-eli-lilly-and-novartis-to-tackle-major-diseases">Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases</a>
Why It Matters: The initiative plans to deploy an initial $100 billion immediately, starting with a 500,000-square-foot data center in Abilene, Texas. Nine additional facilities are planned, with potential expansion to 20 locations.
Technology partners Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) saw their stocks climb on the news. NVIDIA rose 3.95% to $143.15, while Arm jumped 8.94% to $162.60.
OpenAI, maintaining operational responsibility while SoftBank leads financial aspects, stated the project &#8220;will secure American leadership in AI&#8221; and &#8220;create hundreds of thousands of American jobs.&#8221; SoftBank&#8217;s Masayoshi Son will serve as chairman.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/43119464/netflix-raises-prices-16-peter-schiff-warns-of-escalating-inflation-risks-ahead-of-trump-policies">Netflix Raises Prices 16%, Peter Schiff Warns Of Escalating Inflation Risks Ahead Of Trump Policies</a></li>
</ul>
Image via Wikimedia Commons
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

MSFT

NVDA

ORCL

SFTBF

SFTBY

Elon Musk Says Project Stargate Doesn't 'Actually Have The Money' After Trump Announces $500 Billion AI Investment Led By SoftBank, Oracle And OpenAI

Jefferies analyst Dennis Ding upgrades Crinetics Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>) from Hold to Buy and announces $55 price target.

Upgrades

CRNX

Jefferies Upgrades Crinetics Pharmaceuticals to Buy, Announces $55 Price Target

Canaccord Genuity analyst Caitlin Burrows initiates coverage on Orthofix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) with a Buy rating and announces Price Target of $24.

OFIX

Canaccord Genuity Initiates Coverage On Orthofix Medical with Buy Rating, Announces Price Target of $24

Canaccord Genuity analyst Maria Ripps upgrades Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) from Hold to Buy and raises the price target from $940 to $1150.

NFLX

Canaccord Genuity Upgrades Netflix to Buy, Raises Price Target to $1150

HUIZ

Huize Stated That It Served Over 1.3 Million Families With More Than 12 Million Insurance Policies Facilitated And Assisted In Processing 160,800 Insurance Claims (+74.7% YoY) In 2024

Shares of Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) rose sharply in today's pre-market trading as the company reported stronger-than-expected <a href="https://www.benzinga.com/news/earnings/25/01/43114866/netflix-q4-earnings-record-subscribers-nfl-squid-game-push-past-highest-expectations">fourth-quarter financial results</a>.
Netflix reported it added 18.91 million paid subscribers in the fiscal quarter, up 15.9% year-over-year. The company said it sees full-year revenue of $43.5 billion to $44.5 billion, up $0.5 billion from the company's previous range
Netflix shares jumped 14.6% to $996.60 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) gained 58.8% to $0.7833 in pre-market trading. ImmunoPrecise Antibodies recently launched its AI-powered pipeline of both optimized and new therapeutics.</li>
<li>New Era Helium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEHC#NASDAQ">NEHC</a>) rose 42% to $3.89 in pre-market trading. New Era Helium recently announced a joint venture with Sharon AI to construct and develop a 250MW net-zero energy data center..</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) rose 40.2% to $0.8520 in pre-market trading after jumping around 15% on Tuesday.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) gained 25.7% to $1.13 in pre-market trading after jumping 94% on Tuesday.</li>
<li>U.S. Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) gained 21.5% to $4.61 in pre-market trading after surging 63% on Tuesday.</li>
<li>Metagenomi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) gained 20.2% to $3.27 in pre-market trading following a 4% gain on Tuesday.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 14.7% to $54.65 in pre-market trading. Tempus AI shares jumped over 35% on Tuesday after Nancy Pelosi disclosed the purchase of 50 Jan 2026 call options.</li>
<li>CareCloud, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) gained 13.3% to $3.50 in pre-market trading after surging over 10% on Tuesday.</li>
<li>Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) gained 13.2% to $29.63 in pre-market trading after gaining around 7% on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Associated Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AC#NYSE">AC</a>) fell 43.7% to $20.00 in pre-market trading. Associated Capital recently reported estimated fourth quarter and full year results</li>
<li>Star Fashion Culture Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STFS#NASDAQ">STFS</a>) shares fell 20.7% to $10.72 in pre-market trading after dipping around 9% on Tuesday.</li>
<li>HUB Cyber Security Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUBC#NASDAQ">HUBC</a>) fell 19.5% to $0.68 in pre-market trading after the company announced the receipt of a Staff Delisting Notice.</li>
<li>Lisata Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) shares dipped 17.4% to $3.22 in pre-market trading after gaining 5% on Tuesday.</li>
<li>Septerna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) fell 14.4% to $16.01 in pre-market trading after gaining more than 10% on Tuesday.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares tumbled 13.1% to $0.8949 in pre-market trading after the company announced exercise of warrants and issuance of new warrants in a private placement for $3.7 million gross proceeds priced at-the-market.</li>
<li>Dogwood Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) shares fell 13% to $2.74 in pre-market trading. Dogwood Therapeutics shares jumped 68% on Tuesday after the company announced patient dosing for its Phase 2b trial evaluating halneuron will commence in Q1 2025.</li>
<li>AnaptysBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) declined 12.3% to $14.81 in pre-market trading after gaining over 6% on Tuesday.</li>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) fell 11.8% to $4.45 in today's pre-market trading. InMed Pharmaceuticals recently announced that INM-901 reduced Alzheimer &#8216;s-related inflammation in a preclinical study.</li>
<li>Marine Products Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPX#NYSE">MPX</a>) dipped 11.3% to $8.04 in pre-market trading. Marine Products will release its financial results for the fourth quarter on Thursday, Jan. 30, before the market opens.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43096091/jim-cramer-this-tech-stock-is-a-buy-louisiana-pacific-has-been-a-great-stock">Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A &#8216;Great Stock&#8217;</a></li>
</ul>

Pre-Market Outlook

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

SEPN

STFS

USEG

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), Deere &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), Intellia Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Cameco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>), Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>), and Absci Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>).
The trades include defense and energy companies, which have been in focus since the inauguration of Donald Trump. The President signed orders on Monday aimed at making it cheaper for companies to produce oil and gas, which could have an impact on energy companies. Defense stocks have also been in focus due to expectations of a pro-Israel stance from the new administration.
The NTLA Trade
The Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) collectively purchased 91,889 shares of Intellia Therapeutics Inc. Based on the closing price of $9.94, the total value of the trade amounts to approximately $913,580.06. This move indicates Ark&#8217;s continued confidence in the gene-editing sector.
The PATH Trade
Ark Invest sold 21,879 shares of UiPath Inc. through its ARKK fund. Given the closing price of $13.33, the trade is valued at around $291,712.07. This sale suggests a shift in Ark&#8217;s stance on the automation software company.
The DE Trade
Ark Invest&#8217;s ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>) and ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) purchased a total of 3,474 shares of Deere &amp; Co. With the closing price at $463.15, the trade is worth approximately $1,607,571.10.
The CCJ Trade
Ark Invest also bought 17,504 shares of Cameco Corp (CCJ) through its ARKQ fund, valued at approximately $937,589.44 at the closing price of $53.56.
Other Key Trades:
<ul>
<li>Oklo Inc: Ark Invest sold 50333 shares through ARKQ.</li>
<li>Elbit Systems: Ark Invest Sold 2074 shares through ARKQ and 627 shares through ARKX.</li>
<li>Illumina Inc: Ark Invest bought 15876 shares through ARKG.</li>
<li>Absci Corp: Ark Invest bought 79411 shares through ARKG.</li>
<li>Accolade Inc: Ark Invest sold 466,337 shares through ARKG.</li>
</ul>
Photo courtesy: Ark Invest

ABSI

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies

Shares of Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) experienced a 15% surge in premarket trading on Wednesday on the heels of the company announcing a 16%<a href="https://www.benzinga.com/markets/equities/25/01/43119464/netflix-raises-prices-16-peter-schiff-warns-of-escalating-inflation-risks-ahead-of-trump-policies" target="_blank" rel="noreferrer noopener"> price hike for its standard streaming plan.</a>
What Happened: Netflix&#8217;s shares saw an increase of $128.14 in the premarket, following a 1.35% rise at the close of the previous day, ending at $869.68. 
The price increase, which took the&nbsp;ad-free standard plan from $15.49&nbsp;to $17.99 per month, was announced in conjunction with Netflix&#8217;s impressive fourth-quarter earnings report.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/equities/25/01/43118941/oracles-larry-ellison-says-cancer-vaccine-tailored-in-48-hours-could-soon-be-a-reality-as-trump-announces-500-billion-ai-investment" target="_blank" rel="noreferrer noopener">Oracle's Larry Ellison Says Cancer Vaccine Tailored In 48 Hours Could Soon Be A Reality As Trump Announces $500 Billion AI Investment</a>
The earnings report highlighted a 16% year-over-year revenue growth, reaching $10.25 billion, and a subscriber increase of 18.91 million. This surge in subscribers brought the total number of paid memberships to a staggering 301.63 million. The price increase also impacted the premium tier, now priced at $24.99, and the ad-supported option, which rose to $7.99.
Netflix&#8217;s robust performance, marked by a <a href="https://www.benzinga.com/25/01/43114866/netflix-q4-earnings-highlights-nfl-squid-game-power-best-subscriber-growth-in-company-history">record operating income surpassing</a>&nbsp;$10 billion for fiscal 2024,&nbsp;suggests a promising future for the company. Netflix anticipates its 2025 revenue to fall&nbsp;between $43.5 billion and $44.5&nbsp;billion, indicating a 12-14% growth. This projection underscores Netflix&#8217;s relatively&nbsp;small current share of the&nbsp;estimated $650 billion market opportunity&nbsp;across its key regions.
The company&#8217;s strong performance, driven by popular shows like &#8216;Squid Game&#8217; and its NFL content, has led to a significant <a href="https://www.benzinga.com/25/01/43104552/youtube-vs-netflix-streamers-top-usage-leaderboard-in-december-sector-makes-more-gains-on-broadcast-and-cable">increase in its subscriber base.</a> The price hike, which is the largest in the company&#8217;s history, is a bold move that reflects Netflix&#8217;s confidence in its future growth and content offerings.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43118598/warren-buffetts-pilot-co-exits-global-oil-trading-refocuses-on-us-operations-report" target="_blank" rel="noreferrer noopener">Warren Buffett's Pilot Co Exits Global Oil Trading, Refocuses On US Operations: Report</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock

Netflix Rises 15% In Wednesday Premarket As Streaming Giant Hikes Prices Following Record Subscriber Growth

LOGI

Logitech Announced Rally Board 65, An All-in-one Portable Video Conference Solution That Combines Intelligent Audio And Video With A 65" Touchscreen Display

Logitech Introduced Logitech Spot, A Workplace Occupancy And Environmental Sensor That's Simple To Deploy In Nearly Any Space

UTSI

UTStarcom Announced That It Has Been Selected As A Major Winner Of The RFP "Self-developed STN-A Equipment Hardware Production And OEM Procurement Project" From Guangdong Research Institute Of China Telecom Co., Ltd

Marqeta Announced It Is Powering Trading 212's Launch Into 20 Countries In Continental Europe

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is now looking to hire data labelers in Utah for <a href="https://www.benzinga.com/news/24/07/39705124/tesla-giving-special-treatment-to-musk-and-high-profile-vip-drivers-in-fsd-development-report">data from its fleet of vehicles</a> as well as its Tesla bots.
What Happened: Tesla posted job openings on social media platform X and its career page.
The employees will work with in-house tools to label data coming from the company&#8217;s large fleet of vehicles as well as data from its humanoid bots which are under development. The data will include images and videos and the labeling will contribute to advancing the software aimed at making them operate autonomously. 
&#8220;No&nbsp;previous&nbsp;experience in AI or data labeling&nbsp;required. The perfect candidate for this role is adaptable, can apply logic to multiple different scenarios, is attentive to detail, has experience with computers and other software, and enjoys a fast-paced work environment,&#8221;&nbsp;the company says in the job description. The candidate must also have a working knowledge of the laws and rules of the road, it added. 
The job will be full-time and would require the employee to work from 9 am to 5:30 pm for five days a week in Utah.
Why It Matters: Tesla uses the visual road data that it gains from its car fleet to train their software how to respond autonomously to them. The company is hopeful that its autopilot and full self-driving (FSD) software, which currently serve as driver assistance systems, will enable autonomous driving with time and more training. 
Last year, Tesla CEO Elon Musk said that the company would start deploying self-driving Model 3 and Model Y vehicles in Texas and California for ride-hailing in 2025, provided it gets the necessary regulatory clearances.
However, the vehicles might not all operate as driverless robotaxis but with a driver as some states demand it until the company touches certain milestones in terms of miles and hours driven, the company then said. Musk, known for overestimating his company's products, expressed confidence about the&nbsp;<a href="https://www.benzinga.com/top-stories/24/10/41279865/elon-musk-may-unveil-teslas-robotaxi-but-consumers-respond-with-ehhh-new-study-reveals-skepticism-ne" target="_blank" rel="noreferrer noopener">company operating driverless paid rides sometime in 2025</a>.
However, it is important to note that FSD has yet to enable autonomous driving and still requires active driver supervision. 
As for Tesla bots, Musk said in July that the EV company would have "genuinely useful" humanoid robots in low production for use within its factories in 2025. The company will "hopefully" increase production for other customers in 2026, he said.
Musk expects to be&nbsp;<a href="https://www.benzinga.com/news/24/03/37950895/elon-musk-says-cost-of-making-an-optimus-is-half-that-of-manufacturing-a-tesla-ev-despite-complexity" target="_blank" rel="noreferrer noopener">able to sell Optimus, as the bots are called, at $10,000 or $20,000</a>, at a lower price point than Tesla&#8217;s cheapest Model 3 sedan, once it reaches high-volume production.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43090016/which-evs-might-lose-7500-ev-tax-credit-under-trump-administration" target="_blank" rel="noreferrer noopener">Here Are The EVs Which Could Lose $7,500 EV Tax Credit Under Trump Administration</a></li>
<li></li>
</ul>
Image via Tesla

Tech

TSLA

Tesla Looks To Hire Data Labelers To Boost Autonomous Vehicle And Bot Development

Billionaire Peter Thiel, a renowned venture capitalist and co-founder of PayPal Holdings and Palantir Technologies, got into Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investments long before its meteoric bull runs captured the world's attention.
However, the long-held conviction appeared to fade, as apparent from one of his interviews last year.
What happened: During an interview in Jun. 2023, Thiel <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39569413/billionaire-peter-thiel-voices-skepticism-on-bitcoins-future-growth-im-not-sure-its-going-">voiced pessimism about Bitcoin's price rise potential</a>.&nbsp;
"I'm not sure it's going to go up that dramatically from here. We got the ETF edition, and I don't know who else buys it," the venture capitalist said.
Thiel added that the apex cryptocurrency has grown increasingly connected with traditional finance as a result of the launch of spot exchange-traded funds, a deviation from its original cypherpunk, crypto-anarchist narrative.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43119637/michael-saylors-proposal-to-increase-microstratagys-share-count-approved-by-shareholders-more-bitcoin-purchases-on-the-cards">Michael Saylor&#8217;s Proposal To Increase MicroStratagy&#8217;s Share Count Approved By Shareholders — More Bitcoin Purchases On The Cards?</a>
When Thiel made these remarks, Bitcoin traded at $60,320.14 per unit. So, if you set aside his skepticism and invested $1,000 in the asset, you'd have received 0.0165 BTC.
Fast forward to January, and the apex cryptocurrency has made significant strides, exchanging hands at $104,988.38 as of this writing.&nbsp;
So if you'd have resisted selling, the original investment would have turned $1740.52, netting a return of 74% in just about seven months.
Why It Matters: Thiel's venture capital firm, Founders Fund, has had a&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37087400/peter-thiels-founders-fund-bets-big-on-bitcoin-and-ether-with-200m-investment-report#google_vignette" target="_blank" rel="noreferrer noopener">significant history with Bitcoin</a>, first buying the apex digital asset back in 2014.
The fund made a profit of $1.8 billion on its Bitcoin investments by selling just before the 2022 market collapse.
It returned to the market between late summer and early fall of 2023, purchasing $100 million worth of Bitcoin.
Interestingly, in the very same interview where Thiel expressed doubts about Bitcoin, he regretted not purchasing more of the digital currency.
Price Action: At the time of writing, Bitcoin was exchanging hands at $104,988.38, up 2.73% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, the leading cryptocurrency has gained 12.41%.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43118234/president-trump-signs-executive-order-to-pardon-silk-road-creator-ross-ulbricht">President Trump Signs Executive Order To Pardon Silk Road Creator Ross Ulbricht</a></li>
</ul>
Photo By Mark Reinstein On Shutterstock

If You Invested $1,000 In Bitcoin When Billionaire Peter Thiel Said BTC  Might Not Rise 'Dramatically,' Here's How Much You'd Have Made Today

Comments

M3

News

Latest news for M3 (OTC:MTHRF) Stock

Tuesday, October 01, 2019

Monday, September 30, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga